A copper peptide serum can give a private-label line a clear ingredient-led story, but the strongest launch brief is built around formula compatibility, cosmetic wording, and an honest product role—not a long list of promises. For buyers evaluating Lanthome’s PDRN and copper peptide serum, the practical conclusion is to keep the 30 ml liquid-serum format central, validate the final formula and pack together, and turn ingredient interest into a controlled claim and sampling plan.
Ingredient marketing becomes much easier when the physical SKU is described accurately. The referenced PDRN copper peptide serum is listed as a facial serum with PDRN and copper peptides as its main and active ingredients. It is offered in a 30 ml / 1.01 fl oz format, model FAI-FP-E069, rather than as a cream, balm, mask, or treatment device.
The page describes a lightweight serum texture and a clear liquid essence with visible micro-bubbles. Those are useful merchandising details because they help a buyer describe sensory appearance without making an unsupported performance claim. The listed retail format is also compact: the single-package dimensions are 4.8 × 4.8 × 9 cm, with a listed single gross weight of 0.1 kg.
| Brief element | Buyer meaning |
|---|---|
| Facial serum | Keep listing and artwork distinct from creams or balm sticks. |
| PDRN + copper peptides | Establishes an ingredient-led concept, not a complete dossier. |
| 30 ml | Supports a regular-use, starter-kit, or gift-set role. |
Do not treat the listing as a finished regulatory dossier. Ask the supplier to confirm the current INCI list, formula revision, stability status, packaging compatibility, market documents, and the exact version that will be sampled. For range planning, explore the Lanthome Serum collection as a separate liquid-format route.
“Copper peptide” is an ingredient-story umbrella, not a complete manufacturing specification. A buyer should ask which copper-peptide material is intended, how it appears on the final ingredient declaration, what its supplier documentation says, and whether the finished formula remains visually and sensorially consistent throughout its intended shelf life.
Peptides are widely discussed in cosmetic science because they are short amino-acid sequences with roles that depend on identity and context. That does not allow a brand to convert ingredient literature into a promise about every finished serum. The public product page identifies copper peptides, but it does not publish an INCI deck, use level, or a finished-product compatibility report; those are matters for the project file.
The FDA overview of cosmetics explains why cosmetic claims need care: product claims can affect regulatory classification. A strong buyer dossier confirms the declared ingredient, latest formula version, acceptance criteria for appearance and odor, and approved sensorial language such as lightweight, fresh, and easy to layer.
This SKU’s distinct story is the pairing of PDRN and copper peptides in one lightweight serum. The source page describes a dual-action formula and connects it with facial-care routines, the look of dermal density, and a radiant luminous complexion. For private-label work, that creates a useful visual and category position: a modern daily facial serum with an ingredient-forward identity.
The best positioning does not imply that two named ingredients automatically produce two guaranteed outcomes. Frame the line around a clear, lightweight facial serum intended for morning or evening routines, a 30 ml size suited to a regular-use or starter-kit role, and a premium ingredient story. The product page notes that the format can support gift sets, starter kits, or single-SKU assortments.
Lanthome’s PDRN balm stick OEM line guide is a useful adjacent reference because it keeps balm sticks, capsule creams, and face serums in separate texture and retail roles. Use that difference in cross-selling instead of forcing every PDRN product into the same listing language.
The formulation conversation should start early because a clear liquid serum is both a chemical system and a visual object. Buyers often focus on hero ingredients first, then discover late that color, odor, viscosity, bubble appearance, or pack interaction changes the intended presentation. Ask for a sample and assess the final candidate rather than assuming that a reference image predicts the delivered product.
Begin with the base: water phase, humectant strategy, solubilization, preservative approach, pH target, and viscosity goal. The source page calls the texture lightweight, so any proposed adjustment should be checked against that sensory role. If the brand wants a more cushiony feel, a faster dry-down, added fragrance, a different color, or a different bottle, treat each as a new compatibility question.
Ask how the selected copper-peptide material behaves with the intended pH window, preservative system, fragrance or botanical additions, chelating choices, and container-contact materials. Do not publish a preferred pH or an ingredient percentage unless it is documented for the actual finished formula. The European Commission cosmetics regulation portal is a useful primary reference when planning EU-market responsibilities.
A claim system should be drafted before the visual campaign, not after. The public listing uses phrases around the look of dermal density and radiant luminous complexion; use these only as starting language for an internal review. Final copy must match the finished product, the evidence available, and the rules in the markets where the product will be sold.
Buyer-friendly cosmetic wording can focus on appearance, sensorial use, and routine relevance: “lightweight daily facial serum,” “designed for a fresh, luminous-looking routine,” or “a PDRN and copper peptide ingredient story.” Avoid presenting PDRN or copper peptides as a treatment for skin disease, an injury, inflammation, or a guaranteed structural change.
The European Commission common criteria for cosmetic claims gives a helpful framework for substantiation and fairness. Build a claim matrix with exact copy, audience, evidence owner, required review, and territory so sales, design, and marketplace teams use one approved source of truth.
Thirty milliliters is not just a fill size; it is a range-architecture decision. Lanthome lists this serum as 30 ml / 1.01 fl oz and describes it as suitable for regular use, travel-friendly packing, gift sets, starter kits, and single-item assortments. A buyer can turn those facts into a controlled channel plan: a hero serum for a focused routine, a premium add-on in a set, or a compact product for content-led e-commerce.
Keep the package discussion grounded in the actual product. The site lists a compact single package, but an OEM project should reconfirm every dimension, material, label area, component, closure, and shipping configuration against the selected version. If the visual concept centers on the clear essence and micro-bubbles, check how the bottle tint, label coverage, and secondary packaging affect that view.
For broader project context, visit About Lanthome. Bring the target market, sales channel, desired pack appearance, expected launch window, and a preliminary claims list to the discussion; they are more useful than a vague request for a “copper peptide formula.”
Sampling is the point where the ingredient story becomes a launchable product decision. Ask for the current sample specification and record the product name, formula revision, fill size, component set, label status, and date received. Compare the sample with the agreed brief: it should read as a lightweight, clear facial serum and preserve the intended everyday routine role.
Separate decisions into three gates. Gate one is formula and sensory acceptance: texture, appearance, odor, and application. Gate two is packaging acceptance: bottle, dropper, label behavior, shipping presentation, and whether the clear-serum visual remains desirable. Gate three is commercial readiness: final claims, market files, artwork approvals, quantity assumptions, and lead-time confirmation.
Do not infer MOQ, production timing, certification, or finished-product testing from this product page because those details are not listed for this SKU. Before ordering, send a concise inquiry through Lanthome’s contact page with the linked product, target markets, 30 ml or alternative pack request, required visual, proposed brand claims, documents, and sales channels.
It is listed as a facial serum. The product page identifies a lightweight serum texture and a 30 ml / 1.01 fl oz format, so buyer briefs, product listings, and package artwork should retain that serum identity unless a separately approved project changes it.
That wording should not be assumed suitable for a cosmetic. Draft final claims around the finished product, evidence, and target-market review. Appearance-, texture-, and routine-oriented cosmetic language is a more responsible starting point than treatment or medical language.
The product page lists PDRN and copper peptides as the main and active ingredients, but it does not publish the full INCI list. Request the current ingredient declaration and technical documentation for the actual sample or production version.
The source page gives three concrete distinctions: a PDRN-and-copper-peptide concept, a clear lightweight essence with visible micro-bubbles, and a 30 ml facial-serum format. Those characteristics can guide a PDP and photography brief while final benefits remain subject to substantiation.
About the Author
This article was prepared by the Lanthome skincare manufacturing team, with experience in private label formulation, packaging development, quality control, and international OEM/ODM projects.
